Boston ScientificvsJohnson & Johnson

BSX and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

BSX

Boston Scientific Corporation

$43.64

Value $64.8B

+1.42%
BSX's page

Boston Scientific (BSX) has a market value of $64.8B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, BSX moved -57.1% and JNJ +39.7%. The P/E is 18.5 for BSX and 40.8 for JNJ. Dividend yield: BSX none, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BSX$64.8B

    JNJ$657B

    JNJ is 10 times BSX

  • Revenue, 12 months

    BSX$21.1B

    JNJ$99.3B

    JNJ is 4.7 times BSX

  • Net income, 12 months

    BSX$3.5B

    JNJ$16.1B

    JNJ is 4.6 times BSX

  • Operating margin

    BSX18.7%

    JNJ–

  • ROIC

    BSX8.5%

    JNJ12.4%

    3.9 points apart

  • P/E

    BSX18.5

    JNJ40.8

    JNJ is 2.2 times BSX

  • Dividend yield

    BSX0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    BSX+4.9%

    JNJ+92.0%

    87.1 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BSX+4.9%

JNJ+92.0%

10015020025020222023202420252026
Returns by period
PeriodBSXWith dividendsJNJWith dividends
1 year since November 17, 2025-57.1%Price -57.1%+39.7%Price +36.6%
3 years since November 17, 2023-19.7%-7.0% a yearPrice -19.7%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021+4.9%+1.0% a yearPrice +4.9%+92.0%+13.9% a yearPrice +67.0%
10 years since November 18, 2016+104.5%+7.4% a yearPrice +104.5%+208.0%+11.9% a yearPrice +136.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BSXBoston ScientificJNJJohnson & Johnson

Valuation

BSXJNJ
Valuation
Price$43.64$272.70
Market value$64.8B$657B
Enterprise value (EV)$76.1B$685B
P/E18.540.8
P/E, 5-year median57.821.9
P/B2.58.1
EV/EBIT19.438.6
Free cash flow yield5.1%3.1%

Results and growth

BSXJNJ
Results and growth
Revenue, 12 months$21.1B$99.3B
Net income, 12 months$3.5B$16.1B
Free cash flow, 12 months$3.3B$20.6B
Earnings per share, 12 months$2.36$6.59
Revenue growth, year on year19.9%6.1%
Revenue growth a year, past+15.2%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

BSXJNJ
Margins and returns on capital
Gross margin69.2%67.6%
Operating margin18.7%–
Net margin16.6%16.2%
ROIC8.5%12.4%
ROE14.1%19.7%

Balance sheet

BSXJNJ
Balance sheet
Cash$609M$17.2B
Total debt$12.0B$44.7B
Net debt / EBITDA2.11.1
Interest cover10.5×18.0×

Dividends and buybacks

BSXJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BSX or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Boston Scientific or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 10.1 times Boston Scientific ($64.8B), at today's prices.

How did BSX and JNJ stock do over the last 10 years?

Since November 18, 2016, BSX's price moved +104.5% and JNJ's +136.4%. With dividends: BSX +104.5% (+7.4% a year), JNJ +208.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, BSX or JNJ?

The dividend yield at today's price is none for Boston Scientific and 1.94% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of BSX and JNJ?

At today's price, the P/E is 18.5 for BSX and 40.8 for JNJ. The median of the last five years was 57.8 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Boston Scientific or Johnson & Johnson?

Over the last twelve months, the net margin was 16.6% for Boston Scientific and 16.2% for Johnson & Johnson, and the operating margin 18.7% and –. Revenue was $21.1B and $99.3B.

Which is the better investment, Boston Scientific or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.